Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Colorado Blood Cancer Institute
408
mi
from
Denver, CO
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Colorado Blood Cancer Institute
408
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Winship Cancer Institute at Emory University
803
mi
from
Atlanta, GA
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Winship Cancer Institute at Emory University
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Ingalls Cancer Research Center
601
mi
from
Harvey, IL
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Ingalls Cancer Research Center
601
mi
from
Harvey, IL
Click here to add this to my saved trials
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
1285
mi
from
Hackensack, NJ
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
1285
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
1289
mi
from
New York, NY
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
1289
mi
from
New York, NY
Click here to add this to my saved trials
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
898
mi
from
Cleveland, OH
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated:  12/31/1969
Queen Elizabeth II Health Sciences Centre
1828
mi
from
Halifax,
Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
A Phase 1 Multi-Center, Open-Label, Dose-Escalation Study to Determine the Pharmacokinetics and Safety of Pomalidomide When Given in Combination With Low Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma and Impaired Renal Function
Status: Enrolling
Updated: 12/31/1969
Queen Elizabeth II Health Sciences Centre
1828
mi
from
Halifax,
Click here to add this to my saved trials
Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
A Pilot Study of Sorafenib in Patients With Acute Myeloid Leukemia as Peri-Transplant Remission Maintenance
Status: Enrolling
Updated:  12/31/1969
University of Maryland Greenebaum Cancer Center
1148
mi
from
Baltimore, MD
Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
A Pilot Study of Sorafenib in Patients With Acute Myeloid Leukemia as Peri-Transplant Remission Maintenance
Status: Enrolling
Updated: 12/31/1969
University of Maryland Greenebaum Cancer Center
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
A Pilot Study of Sorafenib in Patients With Acute Myeloid Leukemia as Peri-Transplant Remission Maintenance
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
1149
mi
from
Baltimore, MD
Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
A Pilot Study of Sorafenib in Patients With Acute Myeloid Leukemia as Peri-Transplant Remission Maintenance
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
833
mi
from
Tucson, AZ
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
833
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1278
mi
from
Sacramento, CA
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1278
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1143
mi
from
San Diego, CA
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1053
mi
from
Jacksonville, FL
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1053
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1320
mi
from
Miami, FL
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1320
mi
from
Miami, FL
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
610
mi
from
Chicago, IL
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
610
mi
from
Chicago, IL
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
841
mi
from
Detroit, MI
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
841
mi
from
Detroit, MI
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
552
mi
from
Minneapolis, MN
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1193
mi
from
Syracuse, NY
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1193
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
726
mi
from
Cincinnati, OH
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
895
mi
from
Cleveland, OH
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
895
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
810
mi
from
Columbus, OH
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
810
mi
from
Columbus, OH
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1147
mi
from
Hershey, PA
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1147
mi
from
Hershey, PA
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1111
mi
from
Richmond, VA
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1111
mi
from
Richmond, VA
Click here to add this to my saved trials
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated:  12/31/1969
5256
mi
from
Wien,
A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A
A Phase II/III, Multicenter, Partially Randomized, Open Label Trial Investigating Safety and Efficacy of On-demand and Prophylactic Treatment With BAY94-9027 in Severe Hemophilia A
Status: Enrolling
Updated: 12/31/1969
5256
mi
from
Wien,
Click here to add this to my saved trials
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
A Phase I Trial to Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected With PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated:  12/31/1969
City of Hope Medical Center
1152
mi
from
Duarte, CA
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
A Phase I Trial to Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected With PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
Status: Enrolling
Updated: 12/31/1969
City of Hope Medical Center
1152
mi
from
Duarte, CA
Click here to add this to my saved trials
Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease
Placebo Controlled Trial Evaluating Gabapentin for the Treatment of Small Fiber Neuropathic Pain in Patients With Fabry Disease
Status: Enrolling
Updated:  12/31/1969
University of Minnesota, Fariview
552
mi
from
Minneapolis, MN
Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease
Placebo Controlled Trial Evaluating Gabapentin for the Treatment of Small Fiber Neuropathic Pain in Patients With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
University of Minnesota, Fariview
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1149
mi
from
Baltimore, MD
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Highlands Oncology Group, P.A.
234
mi
from
Fayetteville, AR
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Highlands Oncology Group, P.A.
234
mi
from
Fayetteville, AR
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Providence St. Joseph's Medical Center
1171
mi
from
Burbank, CA
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Providence St. Joseph's Medical Center
1171
mi
from
Burbank, CA
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Norwalk Hospital
1318
mi
from
Norwalk, CT
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Norwalk Hospital
1318
mi
from
Norwalk, CT
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Lakeland Regional Cancer Center
1134
mi
from
Lakeland, FL
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Lakeland Regional Cancer Center
1134
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Palm Beach Cancer Institue
1284
mi
from
West Palm Beach, FL
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Palm Beach Cancer Institue
1284
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Ingalls Memorial Hospital
601
mi
from
Harvey, IL
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Ingalls Memorial Hospital
601
mi
from
Harvey, IL
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Indiana Blood & Marrow Transplantation (IBMT)
646
mi
from
Indianapolis, IN
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Indiana Blood & Marrow Transplantation (IBMT)
646
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas
27
mi
from
Wichita, KA
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas
27
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
University of Maryland- Biological Sciences
1146
mi
from
Baltimore, MD
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
University of Maryland- Biological Sciences
1146
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Nebraska Methodist Hospital
260
mi
from
Omaha, NE
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Nebraska Methodist Hospital
260
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Albert Einstein College of Medicine
1295
mi
from
Bronx, NY
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Albert Einstein College of Medicine
1295
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
1289
mi
from
New York, NY
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
1289
mi
from
New York, NY
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
898
mi
from
Cleveland, OH
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Mid Ohio Oncology Hematology, Inc.
810
mi
from
Columbus, OH
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Mid Ohio Oncology Hematology, Inc.
810
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
The Jones Clinic, PC
481
mi
from
Germantown, TN
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
The Jones Clinic, PC
481
mi
from
Germantown, TN
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Sarah Cannon Cancer Center
618
mi
from
Nashville, TN
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Sarah Cannon Cancer Center
618
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Tennessee Oncology, PLLC
558
mi
from
Nashville, TN
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Tennessee Oncology, PLLC
558
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Joe Arrington Cancer Center
368
mi
from
Lubbock, TX
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Joe Arrington Cancer Center
368
mi
from
Lubbock, TX
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
1409
mi
from
Seattle, WA
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
1409
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Dean Medical Center
575
mi
from
Madison, WI
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Dean Medical Center
575
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
636
mi
from
Milwaukee, WI
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
636
mi
from
Milwaukee, WI
Click here to add this to my saved trials